1. Home
  2. NEO vs CXM Comparison

NEO vs CXM Comparison

Compare NEO & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • CXM
  • Stock Information
  • Founded
  • NEO 2001
  • CXM 2009
  • Country
  • NEO United States
  • CXM United States
  • Employees
  • NEO N/A
  • CXM N/A
  • Industry
  • NEO Precision Instruments
  • CXM Computer Software: Prepackaged Software
  • Sector
  • NEO Health Care
  • CXM Technology
  • Exchange
  • NEO Nasdaq
  • CXM Nasdaq
  • Market Cap
  • NEO 1.9B
  • CXM 2.1B
  • IPO Year
  • NEO 1999
  • CXM 2021
  • Fundamental
  • Price
  • NEO $14.11
  • CXM $8.88
  • Analyst Decision
  • NEO Strong Buy
  • CXM Hold
  • Analyst Count
  • NEO 10
  • CXM 15
  • Target Price
  • NEO $20.44
  • CXM $9.89
  • AVG Volume (30 Days)
  • NEO 1.2M
  • CXM 1.3M
  • Earning Date
  • NEO 02-18-2025
  • CXM 03-26-2025
  • Dividend Yield
  • NEO N/A
  • CXM N/A
  • EPS Growth
  • NEO N/A
  • CXM 36.57
  • EPS
  • NEO N/A
  • CXM 0.15
  • Revenue
  • NEO $644,118,000.00
  • CXM $788,062,000.00
  • Revenue This Year
  • NEO $13.00
  • CXM $9.55
  • Revenue Next Year
  • NEO $10.10
  • CXM $3.49
  • P/E Ratio
  • NEO N/A
  • CXM $58.86
  • Revenue Growth
  • NEO 12.06
  • CXM 12.02
  • 52 Week Low
  • NEO $12.13
  • CXM $6.91
  • 52 Week High
  • NEO $19.11
  • CXM $14.32
  • Technical
  • Relative Strength Index (RSI)
  • NEO 40.08
  • CXM 54.46
  • Support Level
  • NEO $13.76
  • CXM $8.50
  • Resistance Level
  • NEO $15.26
  • CXM $9.36
  • Average True Range (ATR)
  • NEO 0.68
  • CXM 0.31
  • MACD
  • NEO -0.02
  • CXM 0.02
  • Stochastic Oscillator
  • NEO 7.85
  • CXM 42.64

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in providing enterprise software that enables every customer-facing function across the front office, from Customer Care to Marketing, to collaborate across internal silos, and communicate across digital channels. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in Americas, EMEA and other countries. It derives maximum revenue from Americas.

Share on Social Networks: